
AbInitio Bio
The Intelligence layer for Drug Manufacturing
Boston, US
Abinitio Bio builds foundation models for biomanufacturing, validated against wet lab data. Our first model, Echo, predicts manufacturing outcomes more accurately than standard models, and any pharma or CDMO can adapt it to their own workflow instantly. By making process decisions that take 6-18 months today in hours, we help teams avoid the cost of delay on a single program.
Meet the team2
The people behind AbInitio Bio
Daniel Mukasa
Founder & CEO
Nisha Gopal
Founder